share_log
Moomoo 24/7 ·  02/29 10:45

Ironwood Pharmaceuticals Shares Are Trading Lower After the Company's Phase 3 Trial of Once-weekly Subcutaneous Apraglutide Did Not Meet Two Out of Four Key Secondary Endpoints

Ironwood Pharmicals的股价走低,此前该公司每周一次的皮下阿普拉鲁肽的第三阶段试验未达到四个关键次要终点中的两个

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发